 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Current Price	$25.99
Prev Close	$26.11
Open	$26.20
Dividend Yield	0.00%
50-Day Moving Average	$31.78
Beta	0.92
Avg. Volume	254,514.14
PE Ratio	-4.34

52-Week High	$76.36
52-Week Low	$22.80
Market Capitalization	$547.23M
EPS	-$5.98
Price to Book	2.03
Revenue Per Employee	$507,350.00
Enterprise Value/EBITDA	-5.29

ENTA Enanta Pharmaceuticals Inc

About

Feed

Fundamentals

News